+ Filter
Loading...
CTAG1B
Loading...Anti-CTAG1B Products
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: BV421
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: PE
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, IHC, FuncS
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, IHC
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, IHC
-
- Class: Class I
- Antigen: NY-ESO-1C9V
- Antigen Species: Human
- Peptide: SLLMWITQV
- Conjugate: BV421
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, ICC, IF, IHC
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- APC-A*02:01/Human NY-ESO (LMWITQAFL) MHC Tetramer (MHC-CN0175)
-
- Class: Class I
- Antigen: NY-ESO
- Antigen Species: Human
- Peptide: LMWITQAFL
- Conjugate: APC
- PE-A*02:01/Human NY-ESO (LMWITQAFL) MHC Tetramer (MHC-CN0176)
-
- Class: Class I
- Antigen: NY-ESO
- Antigen Species: Human
- Peptide: LMWITQAFL
- Conjugate: PE
-
- Class: Class II
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQCFLPVF
- Conjugate: PE
-
- Class: Class II
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQCFLPVF
- Conjugate: APC
- PE-A*02:01/Human CTAG1B (SLLMWITQL) MHC Tetramer (MHC-LC1499)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQL
- Conjugate: PE
- APC-A*02:01/Human CTAG1B (SLLMWITQA) MHC Tetramer (MHC-LC1242)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQA
- Conjugate: APC
- APC-A*02:01/Human CTAG1B (SLLMWITQS) MHC Tetramer (MHC-LC1245)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQS
- Conjugate: APC
- APC-A*02:01/Human CTAG1B (SLLMWITQL) MHC Tetramer (MHC-LC1500)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQL
- Conjugate: APC
- BV421-A*02:01/Human CTAG1B (SLLMWITQA) MHC Tetramer (MHC-LC1243)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQA
- Conjugate: BV421
- BV421-A*02:01/Human CTAG1B (SLLMWITQS) MHC Tetramer (MHC-LC1246)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQS
- Conjugate: BV421
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: APC
-
- Class: Class I
- Antigen: NY-ESO-1 C9V
- Antigen Species: Human
- Peptide: SLLMWITQV
- Conjugate: PE
-
- Class: Class I
- Antigen: NY-ESO-1 C9V
- Antigen Species: Human
- Peptide: SLLMWITQV
- Conjugate: APC
- A*0201/Human NY-ESO-1 (SLLMWITQC) MHC Tetramer (MHC-LC705)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQC
- PE-A*02:01/Human CTAG1B (SLLMWITQA) MHC Tetramer (MHC-LC1241)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQA
- Conjugate: PE
- PE-A*02:01/Human CTAG1B (SLLMWITQS) MHC Tetramer (MHC-LC1244)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQS
- Conjugate: PE
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: PE
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: APC
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: BV421
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
- Mouse Anti-CTAG1B Recombinant Antibody (clone ZN72) (VS3-FY1582)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: IHC-P
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
-
- Class: Class II
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: LKEFTVSGNILTIRL
- Conjugate: Biotin
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
-
- Class: Class II
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: LLEFYLAMPFATPME
- Conjugate: Biotin
- A*02:01/Human NY-ESO-1 (SLLMWITQV) MHC Monomer (MHC-YF228)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQV
- Conjugate: Biotin
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
- Human Anti-Cancer/testis antigen 1 Recombinant Soluble TCR (KFJ5) (scTCR-071ZP-S(P))
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
- A*02:01/Human NY-ESO-1 (SLLMWITQC) MHC Monomer (MHC-YF002)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: Biotin
-
- Class: Class II
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: LLEFYLAMPFATPME
- Conjugate: Biotin
-
- Class: Class II
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: LLEFYLAMPFATPME
- Conjugate: Biotin
-
- Class: Class II
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: LKEFTVSGNILTIRL
- Conjugate: Biotin
- FITC-B*51:01/Human CTAG1B (MPFATPMEA) MHC Tetramer (MHC-CN0551)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: FITC
- B*51:01/Human CTAG1B (MPFATPMEA) MHC Tetramer (MHC-CN0552)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: Unconjugated
- Human Anti-Cancer/testis antigen 1 Recombinant Soluble TCR (1G4) (scTCR-067ZP-S(P))
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
- Human Anti-Cancer/testis antigen 1 Recombinant Soluble TCR (C49c50) (scTCR-068ZP-S(P))
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
- Human Anti-Cancer/testis antigen 1 Recombinant Soluble TCR (IG4) (scTCR-069ZP-S(P))
-
- Species Reactivity: Homo sapiens
- Epitope: SLLMWITQC
- MHC: HLA-A*0201
- Human Anti-Cancer/testis antigen 1 Recombinant Soluble TCR (KFJ37) (scTCR-070ZP-S(P))
-
- Species Reactivity: Homo sapiens
- Epitope: APRGPHGGAASGL
- MHC: HLA-B7
- PE-A*68:01/Human CTAG1B (TVSGNILTIR) MHC Tetramer (MHC-CN0545)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: TVSGNILTIR
- Conjugate: PE
- APC-A*68:01/Human CTAG1B (TVSGNILTIR) MHC Tetramer (MHC-CN0546)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: TVSGNILTIR
- Conjugate: APC
- FITC-A*68:01/Human CTAG1B (TVSGNILTIR) MHC Tetramer (MHC-CN0547)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: TVSGNILTIR
- Conjugate: FITC
- A*68:01/Human CTAG1B (TVSGNILTIR) MHC Tetramer (MHC-CN0548)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: TVSGNILTIR
- Conjugate: Unconjugated
- PE-B*51:01/Human CTAG1B (MPFATPMEA) MHC Tetramer (MHC-CN0549)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: PE
- APC-B*51:01/Human CTAG1B (MPFATPMEA) MHC Tetramer (MHC-CN0550)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: MPFATPMEA
- Conjugate: APC
-
- Class: Class II
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQCFLPVF
- Conjugate: FITC
-
- Class: Class II
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQCFLPVF
- Conjugate: Unconjugated
- PE-A*02:01/Human CTAG1B (SLLMWITQC) MHC Tetramer (MHC-CN0541)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: PE
- APC-A*02:01/Human CTAG1B (SLLMWITQC) MHC Tetramer (MHC-CN0542)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: APC
- FITC-A*02:01/Human CTAG1B (SLLMWITQC) MHC Tetramer (MHC-CN0543)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: FITC
- A*02:01/Human CTAG1B (SLLMWITQC) MHC Tetramer (MHC-CN0544)
-
- Class: Class I
- Antigen: CTAG1B
- Antigen Species: Human
- Peptide: SLLMWITQC
- Conjugate: Unconjugated
- BV421-A*02:01/Human CTAG1B (SLLMWITQL) MHC Tetramer (MHC-LC1501)
-
- Class: Class I
- Antigen: NY-ESO-1
- Antigen Species: Human
- Peptide: SLLMWITQL
- Conjugate: BV421
-
- Derivation: Phage display library
- Species Reactivity: Mouse, Human
- Type: Rabbit IgG
- Application: IHC-P
- Anti-CTAG1B Immunohistochemistry Kit (VS-0525-XY1746)
-
- Species Reactivity: Human
- Target: CTAG1B
- Application: IHC
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CTAG1B, also known as melanoma antigen family A1 (MAGE-A1), is a cancer/testis antigen (CTA) that is normally expressed in germ cells of the testes and placenta but is aberrantly activated and expressed in a variety of tumor types. Due to its restricted expression in normal tissues and its significant presence in malignant cells, CTAG1B has become a target of interest in cancer immunotherapy. It is involved in cell cycle regulation and may contribute to tumor cell proliferation and survival. The identification of CTAG1B in various cancers has led to the development of immunotherapeutic strategies, including cancer vaccines and T-cell therapies, aiming to elicit an immune response specifically against CTAG1B-expressing tumor cells. Research continues to explore the exact mechanisms by which CTAG1B contributes to tumorigenesis and to optimize its use as a target in cancer treatment.

